The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Each podcast is certified for .5 credits.
Estimated Time to Complete Activity: 30 minutes per podcast
After participating in this activity, the participant will demonstrate the ability to:
- Identify and implement new therapies for treating patients with neovascular AMD.
- Distinguish between new retinal vein occlusion treatment approaches and choose the most appropriate therapeutic option.
- Integrate new diabetic retinopathy and diabetic macular edema research findings into current treatment paradigms.
- Demonstrate knowledge of new therapies by developing best practices in treating vitreomacular abnormalities.
- Clinicians lack confidence that their knowledge of new AMD developments will allow them to provide optimal patient care.
- Clinicians are unprepared to integrate new diabetic retinopathy and diabetic macular edema research findings into their current treatment paradigms.
- On-going research into retinal vein occlusion treatments has created clinician uncertainty about choosing the most appropriate therapeutic options.
- Clinicians require additional knowledge about new therapies to develop best practices in treating vitreomacular abnormalities.
The Office of Continuing Medical Education (CME) at The Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. The Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.
Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request
The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
This activity has been developed for ophthalmologists and retina specialists.
June 19, 2014, activities expire 2 years from the date of publication.
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) to require signed disclosure of the existence of financial relationships with industry from any individual in a position to control the content of a CME activity sponsored by OCME. Members of the Planning Committee are required to disclose all relationships regardless of their relevance to the content of the activity. Faculty are required to disclose only those relationships that are relevant to their specific presentation. The following relationships have been reported for this activity:
Neil M. Bressler, MD has disclosed that, in the past year, he has served as a principal investigator of research projects at the Johns Hopkins University sponsored by Bayer, Genentech, Novartis, and Regeneron.
Susan Bressler, MD has disclosed that in the past year she has been an investigator in research at the Johns Hopkins University School of Medicine sponsored by Allergan USA Inc, Bausch and Lomb, Bayer Healthcare Pharmaceuticals, Lumenis, Inc, Notal Vision Ltd., Novartis Pharmaceuticals Inc, Regeneron Pharmaceuticals, Sanofi-Aventis Group, ThromboGenics NV, Boehringer Ingelheim Pharma, Genentech, and has consulted for GlaxoSmithKline.
No other planners have indicated that they have any financial interests or relationships with a commercial entity.
Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
To successfully complete this activity, participants must read the content, and then link to the Johns Hopkins University School of Medicine's website to complete the post-test with a passing grade, and complete the evaluation. Once you receive a passing grade, you can access and print your certificate of credit.
There are no fees or prerequisites for this activity.
This activity is supported by educational grants from Alcon Laboratories, Genentech, Inc., Regeneron Pharmaceuticals, Inc.
I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the Privacy Regulations). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
"The Office of Continuing Medical Education at The Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."
For CME Questions, please contact the CME Office, (410) 955-2959 or email: firstname.lastname@example.org. For CME Certificates, please call (410) 502-9634.
Johns Hopkins University School of Medicine Office of Continuing Medical Education Turner 20/720 Rutland Avenue Baltimore, Maryland 21205-2195.
Reviewed and Approved by
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)
Pentium 800 processor or greater, Windows 98/NT/2000/XP or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K Modem or better, Windows Media Player 9.0 or later, 128 MB of RAM Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader, storage, internet connectivity, and minimum connection speed.
Copyright © JHUSOM and eOphthalmology Review | Presented by JHUSOM in collaboration with DKBmed.